Skip to main content
. 2020 Nov 25;75:e2273. doi: 10.6061/clinics/2020/e2273

Table 3. Relationship between number of comorbidities and risk of death according to viral agent in pediatric patients with severe acute respiratory infection.

Frequency Crude model Adjusted model*
Number of comorbidities N % OR 95% CI p OR 95% CI p
Influenza
    0 477 72.4 1.00 1.00
    1 143 21.7 2.16 0.87-5.34 0.09 2.12 0.86-5.26 0.103
    ≥2 39 5.9 5.84 2.09-16.38 0.001 5.73 2.04-16.11 0.001
Other respiratory virus
    0 876 69.3 1.00 1.00
    1 300 23.7 2.47 1.33-4.56 0.004 2.51 1.35-4.69 0.004
    ≥2 88 6.9 2.65 1.06-6.64 0.038 2.71 1.06-6.96 0.037
SARS-CoV-2
    0 1584 61.6 1.00 1.00
    1 707 27.5 3.01 2.32-3.91 <0.001 3.03 2.34-3.94 <0.001
    ≥2 279 10.9 4.76 3.45-6.56 <0.001 4.81 3.48-6.63 <0.001

Data represent closed cases entered into the National Epidemiological Surveillance Information System between January 1st and July 14th, 2020. Absence of information on a comorbidity was assumed to indicate absence of comorbidity.

*

Adjusted for sex and age.

ORV=other respiratory virus (respiratory syncytial virus, adenovirus, parainfluenza 1, parainfluenza 2, parainfluenza 3, parainfluenza 4, metapneumovirus, bocavirus, rhinovirus); OR=odds ratio; 95% CI=95% confidence interval.